These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7325045)

  • 1. Tissue culture studies of neuroelectric blocking factors.
    Seil FJ
    Adv Neurol; 1981; 31():281-8. PubMed ID: 7325045
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroelectric blocking factors in multiple sclerosis and normal human sera.
    Seil FJ; Leiman AL; Kelly JM
    Arch Neurol; 1976 Jun; 33(6):418-22. PubMed ID: 938266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroelectric blocking factors in human and animal sera evaluated using the isolated frog spinal cord.
    Schauf CL; Davis FA; Sack DA; Reed BJ; Kesler RL
    J Neurol Neurosurg Psychiatry; 1976 Jul; 39(7):680-5. PubMed ID: 1086889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Destruction of nerve cells cultured "in vitro" by lymphocytes from patients with multiple sclerosis. Auto-immune pathogenesis of multiple sclerosis].
    Halpern B; Bakouche P; Martial-Lasfargues C
    Presse Med (1893); 1969 Dec; 77(55):2103-6. PubMed ID: 4190510
    [No Abstract]   [Full Text] [Related]  

  • 5. The occurrence, specificity, and role of neuroelectric blocking factors in multiple sclerosis.
    Schauf CL; Davis FA
    Neurology; 1978 Sep; 28(9 Pt 2):34-9. PubMed ID: 568750
    [No Abstract]   [Full Text] [Related]  

  • 6. Depression of complex bioelectric discharges in cerebral tissue cultures by thermolabile complement-dependent serum factors.
    Crain SM; Bornstein MB
    Exp Neurol; 1975 Oct; 49(1 Pt 1):330-5. PubMed ID: 52559
    [No Abstract]   [Full Text] [Related]  

  • 7. Neural blocking activity of multiple sclerosis and EAE sera.
    Davis FA; Schauf CL
    Neurology; 1976 Jun; 26(6 PT 2):43-4. PubMed ID: 1083963
    [No Abstract]   [Full Text] [Related]  

  • 8. [Asparginase in experimental allergic encephalomyelitis. V. Asparginase in the organs and blood serum of some animal species].
    Turský T; Valovicová E
    Biologia (Bratisl); 1967; 22(1):39-44. PubMed ID: 6043118
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyslipoproteinemia in the pathogenesis of disseminated sclerosis].
    Akimov GA; Golovkin VI; Matveeva TS; Pleskov VM
    Sov Med; 1984; (5):54-7. PubMed ID: 6463723
    [No Abstract]   [Full Text] [Related]  

  • 10. Morphological changes in the skin during experimental allergic encephalomyelitis and multiple sclerosis: bases for new diagnostic test.
    Bisaga GN; Onishchenko LS; Adel'son LN
    Bull Exp Biol Med; 2000 Oct; 130(10):1005-10. PubMed ID: 11177306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunopathogenesis of multiple sclerosis.
    Bornstein MB
    Mt Sinai J Med; 1974; 41(1):46-55. PubMed ID: 4544515
    [No Abstract]   [Full Text] [Related]  

  • 12. [Components of kallikrein-kinin system in experimental and clinical neuroallergy].
    Kozlova LS; Trapezontseva RA; Vilkov GA
    Vopr Med Khim; 1982; 28(3):131-4. PubMed ID: 6920947
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of a rat model of experimental autoimmune encephalomyelitis with human MBP as antigen.
    Guo L; Li Y; Lin H; Ji X; Li J; Que L; Zhang Y; Rong Y; Wang J
    Cell Mol Immunol; 2004 Oct; 1(5):387-91. PubMed ID: 16285900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitis.
    Verda L; Luo K; Kim DA; Bronesky D; Kohm AP; Miller SD; Statkute L; Oyama Y; Burt RK
    Bone Marrow Transplant; 2006 Sep; 38(6):453-60. PubMed ID: 16951693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Culture of human and aminal nerve tissue and its use for the study of central nervous system diseases].
    Gosheva AE; Buravlev VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(7):1091-7. PubMed ID: 4563841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Uric acid as a scavenger in oxidative stress].
    Staub M
    Orv Hetil; 1999 Feb; 140(6):275-9. PubMed ID: 10071505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
    J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viruses isolated from patients with encephalomyelitis and multiple sclerosis. I. Pathogenic and antigenic properties.
    Bychkova EN
    Fed Proc Transl Suppl; 1965; 24(4):742-4. PubMed ID: 4953628
    [No Abstract]   [Full Text] [Related]  

  • 19. [Substances involved in nerve conduction in nerve degeneration].
    Umrath K; Bohn H; Klemencic E
    Z Biol; 1966 Feb; 115(3):165-70. PubMed ID: 5915873
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Espejo C; Martínez-Cáceres EM
    Ann N Y Acad Sci; 2005 Jun; 1051():88-96. PubMed ID: 16126947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.